"Hemostatics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure.
Descriptor ID |
D006490
|
MeSH Number(s) |
D27.505.954.502.270.463
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hemostatics".
Below are MeSH descriptors whose meaning is more specific than "Hemostatics".
This graph shows the total number of publications written about "Hemostatics" by people in this website by year, and whether "Hemostatics" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 1 | 0 | 1 |
2002 | 0 | 1 | 1 |
2003 | 0 | 1 | 1 |
2005 | 2 | 1 | 3 |
2006 | 1 | 1 | 2 |
2008 | 2 | 0 | 2 |
2009 | 0 | 1 | 1 |
2010 | 1 | 0 | 1 |
2011 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hemostatics" by people in Profiles.
-
Marar TT, Martinez ND, Maroney SA, Siebert AE, Wu J, Stalker TJ, Tomaiuolo M, Delacroix S, Simari RD, Mast AE, Brass LF. The contribution of TFPIa to the hemostatic response to injury in mice. J Thromb Haemost. 2021 09; 19(9):2182-2192.
-
Tondelli TO, Winokur RS, Sista AK. Use of the VASCADE Arterial Closure Device to Achieve Hemostasis after a Deep Venous Procedure. J Vasc Interv Radiol. 2015 Sep; 26(9):1409-10.
-
Ivanciu L, Toso R, Margaritis P, Pavani G, Kim H, Schlachterman A, Liu JH, Clerin V, Pittman DD, Rose-Miranda R, Shields KM, Erbe DV, Tobin JF, Arruda VR, Camire RM. A zymogen-like factor Xa variant corrects the coagulation defect in hemophilia. Nat Biotechnol. 2011 Oct 23; 29(11):1028-33.
-
Minshall RD, Vandenbroucke EE, Holinstat M, Place AT, Tiruppathi C, Vogel SM, van Nieuw Amerongen GP, Mehta D, Malik AB. Role of protein kinase Czeta in thrombin-induced RhoA activation and inter-endothelial gap formation of human dermal microvessel endothelial cell monolayers. Microvasc Res. 2010 Sep; 80(2):240-9.
-
Bildzukewicz NA, Durkan B, Maxwell PJ, Isenberg GA. A pseudoaneurysm of the inferior epigastric artery after laparoscopic right hemicolectomy. Am Surg. 2009 Dec; 75(12):1266-8.
-
Aljamali MN, Margaritis P, Schlachterman A, Tai SJ, Roy E, Bunte R, Camire RM, High KA. Long-term expression of murine activated factor VII is safe, but elevated levels cause premature mortality. J Clin Invest. 2008 May; 118(5):1825-34.
-
Doria C, Fischer CP, Wood CG, Li PM, Marra S, Hart J. Phase 3, randomized, double-blind study of plasma-derived human thrombin versus bovine thrombin in achieving hemostasis in patients undergoing surgery. Curr Med Res Opin. 2008 Mar; 24(3):785-94.
-
Veznedaroglu E, Nelson PK, Jabbour PM, Rosenwasser RH. Endovascular treatment of spinal cord arteriovenous malformations. Neurosurgery. 2006 Nov; 59(5 Suppl 3):S202-9; discussion S3-13.
-
Mayer SA, Rincon F. Ultra-early hemostatic therapy for acute intracerebral hemorrhage. Semin Hematol. 2006 Jan; 43(1 Suppl 1):S70-6.
-
Brown DB, Pilgram TK, Darcy MD, Fundakowski CE, Lisker-Melman M, Chapman WC, Crippin JS. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents. J Vasc Interv Radiol. 2005 Dec; 16(12):1661-6.